Abstract:Atrial natriuretic peptide (ANP), a small peptide consisting of 28 amino acids, has been applied in clinical treatment for heart failure, but it can encounter proteolytic degradation during its expression in host cells. Therefore, it is usually reported that ANP was expressed as a part of fusion protein. The aim of our study was to use an overexpression system to express the fusion protein REF-ANP and to optimize a purification method. First, Escherichia coli DH5alpha was transformed with constructed expression vector containing two tandem copies of ref-anp gene and the fusion protein REF-ANP was overexpressed in shaking flask culture. Subsequently, the inclusion bodies were purified with reverse phase chromatography and pooled fractions were lyophilized. After this step, REF-ANP can be solubilized under native conditions without urea. After cleavage reaction, the sample was subjected to size exclusion chromatography and then rANP was polished with reverse phase chromatography. The final purity of rANP was more than 98% and the recovery of rANP per liter of shaking flask culture was more than 3mg. Such methods as mass spectrometry, capillary isoelectrofocusing analysis, and N-terminal amino acid sequence were used to identify rANP. The capillary isoelectrofocusing analysis showed that the pI of ANP was about pH 9.7. In this study, an efficient refolding and purification process should make scaling-up procedures easier and more successful than earlier reports. Moreover, it is possible that the refolding and purification method along with the overexpression system described in this article may offer new ideas on optimizing expression and purification of other kinds of short peptides.

Prokaryotic Expression Purification and Identification of Human Amino-Terminal Pro-Brain Natriuretic Peptide and Its Stability

Construction of Recombinant NNMT Plasmid and Expression in E. Coli

Construction and Expression of Recombinant Human B-type Natriuretic Peptide (Hbnp-32)

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Heterologous high yield expression and purification of neurotensin and its functional fragment in Escherichia coli

Prokaryotic Expression and Purification of Human GST-14-3-3σFusion Protein and Its Activity Detection

[High Level Expression of Human Atrial Natriuretic Peptide in Fusion Form in E. Coli System].

Cloning, Construction and Purification of Recombinant Human B-type Natriuretic Peptide

[Prokaryotic Expression, Purification and Identification of NY-ESO-1/GST Fusion Protein in E.coli].

Expression, Purification and Transduction Activity Identification of TAT-NEP1-40

High Efficient Expression and Purification of the Escherichia Coli T-protein

Expression and Purification of Soluble Human Neutrophil Gelatinase Associated Lipocalin in E.coli

High yield expression and purification of full-length Neurotensin with pyroglutamate modification

Prokaryotic Expression,purification and Identification of GST-human S100A9 Fusion Protein

Cloning and Expression of Tnl(84-330bp)Stable Fragment

Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli

Highly Efficient Expression and Purification of Human HMGB1 Gene in E.coli

The Purification of GST-NDPK-A Fusion Protein and Detection of its Interacting Proteins in vitro

Construction , Expression of Ctni(28-110Aa)-linker-tnc Fusion Protein and Its Identification

Over-expression in E.coli and Purification of PTI-1 Protein

Prokaryotic expression and antigenicity analysis of N-terminal fragment of human LBP